Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2003
Business Overview: Humana is a major health benefits company offering coordinated health insurance coverage through traditional and Internet-based plans for employer groups, government-sponsored programs, and individuals. As of March 31, 2003, the company served approximately 6.6 million medical insurance members and 1.7 million specialty product members. Operations are managed through two segments: Commercial (employer groups and individuals) and Government (Medicare+Choice, Medicaid, and TRICARE).
Key Financial Metrics
| Metric (in thousands) | Q1 2003 | Q1 2002 |
|---|---|---|
| Total Revenues | $2,931,716 | $2,732,582 |
| Net Income | $31,230 | $46,770 |
| Diluted EPS | $0.19 | $0.28 |
| Operating Cash Flow | ($108,230) Used | ($140,137) Used |
| Cash and Equivalents (End of Period) | $532,652 | $485,882 |
| Total Debt (Short + Long Term) | $599,328 | N/A |
| Medical Expense Ratio (MER) | 83.4% | 83.1% |
| SG&A Expense Ratio | 15.4% | 16.1% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 7.3% to $2.93 billion, driven primarily by a 13.3% increase in Commercial segment premiums due to higher premium yields (13-15% range) and slight membership growth.
- Profitability Decline: Net income decreased 33% to $31.2 million. This decline was primarily caused by a non-cash restructuring charge of $30.8 million ($18.8 million after tax) related to the consolidation of customer service centers and workforce reduction.
- Segment Performance:
- Commercial: Income before taxes rose to $37.2 million from $26.1 million, aided by improved Medical Expense Ratios (81.3% vs 81.9%) and SG&A ratios.
- Government: Income before taxes fell sharply to $10.2 million from $42.7 million. This was due to a 170 basis point increase in the Medical Expense Ratio (86.2% vs 84.5%) driven by higher utilization in TRICARE operations and a 10.1% decline in Medicare+Choice membership.
- Membership Trends: Total medical membership grew 1.4% to 6.6 million. Commercial membership grew 1.7%, while Government membership grew 1.1%, offset by a significant drop in Medicare+Choice members.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Commercial Strategy: Management expects Commercial premium yields to remain in the 13-15% range for the remainder of 2003. Commercial medical membership is projected to grow 2-4% by year-end.
- Government Strategy: Medicare+Choice membership is expected to decline further to between 310,000 and 320,000 by December 31, 2003, with premium yields expected to remain in the 4-6% range.
- TRICARE Transition: The company is bidding for the new TRICARE Next Generation (T-Nex) contracts. If awarded the South region, TRICARE revenues and expenses are expected to decline by approximately 20% due to the exclusion of certain benefits (e.g., pharmacy) under the new structure.
- Capital Allocation: The company repurchased 2.2 million shares for $20.8 million in Q1 2003. Remaining authorization is $5.1 million. Capital expenditures for 2003 are projected at approximately $105 million, focused on technology.
Risks and Contingencies
- Legal Proceedings: Humana is a defendant in significant class action litigation, including "subscriber track" cases alleging RICO violations and "provider track" cases alleging improper claim payments. A trial for individual subscriber claims is set for September 2003, and a provider track trial is set for December 2003.
- Regulatory Environment: The company faces scrutiny regarding claims payment practices and utilization management. Legislative proposals regarding Medicare+Choice reimbursement rates and the implementation of HIPAA privacy and security rules pose potential cost and operational risks.
- Government Contract Risk: A significant portion of revenue relies on government contracts (TRICARE, Medicare+Choice, Medicaid). Changes in reimbursement rates, contract non-renewal, or legislative changes could materially impact financial results.
- Restructuring: The company is in the midst of a major restructuring plan to reduce administrative costs, involving the elimination of approximately 2,300 net positions by year-end 2003.
Investor Verification Checklist
- Restructuring Impact: Verify the actual cash outflow for severance and lease discontinuance versus the non-cash impairment charges recorded in Q1.
- TRICARE Receivables: Confirm the collectability of the $358.6 million in TRICARE receivables, specifically regarding Bid Price Adjustments (BPAs) and Change Orders.
- Medicare+Choice Attrition: Monitor the rate of membership decline in the Medicare+Choice segment against the projected year-end range of 310,000-320,000 members.
- Legal Exposure: Assess the potential financial impact of the pending class action trials scheduled for late 2003, particularly regarding RICO claims and provider disputes.
- Medical Cost Trends: Track the Medical Expense Ratio in the Government segment, specifically TRICARE, to ensure utilization increases do not further erode margins.